Top Markets
Coin of the day
CytoMed Therapeutics Limited CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC
Peringkat dalam Saham #32327
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical... CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
Harga Saham
$0.88
Terakhir disinkronkan: 2026-08-17
Kapitalisasi Pasar
$10.41M
Perubahan (1 hari)
-7.26%
Perubahan (1 tahun)
-50.56%
Negara
SG
Perdagangan CytoMed Therapeutics Limited (GDTC)

Kategori

Riwayat harga saham CytoMed Therapeutics Limited (GDTC)
Harga penutupan tertinggi: $0.84 pada 2026-08-01

Harga penutupan terendah: $3.48 pada 2023-04-01
Riwayat harga saham CytoMed Therapeutics Limited dari 2023 hingga 2026
Performa harga saham tahunan
Tahun Performa
2026 (TTM) -14.06%
2025 -41.13%
2024 -30.38%
2023 0.00%
Harga saham perusahaan atau pesaing serupa
Perusahaan Harga saham Perubahan 1th% Negara
$515.58 32.24%
US
$992.01 50.00%
NL
$111.24 -36.86%
AU
$736.64 6.99%
CH
$1.05K -7.55%
KR